Showing 21 - 40 results of 99,970 for search '(( 50 mg decrease ) OR ( 5 ((((nn decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.26s Refine Results
  1. 21

    Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

    Published 2011
    “…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
  2. 22
  3. 23
  4. 24
  5. 25

    Complete data. by Jan Víteček (11434774)

    Published 2024
    “…A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”
  6. 26

    Fig 4 - by Jan Víteček (11434774)

    Published 2024
    “…A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”
  7. 27
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33
  14. 34

    Fig 5 - by Dalia Zaafar (6693017)

    Published 2022
    Subjects:
  15. 35

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40